BLNC
Balance Labs, Inc.Company Information
- Company Name
- Balance Labs, Inc.
- CIK
- CIK0001632121
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BLNC: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 07 Trade & Services
- SIC
- 8742
- SIC Description
- Services-Management Consulting Services
- Ticker
- BLNC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Marketable Securities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Unbilled Receivables Current | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | 0 | 0 | 0 | 1 | 1 | 1 | 2 | - | - | - | - | - | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 0 | 0 | - | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Derivative Liabilities Current | 1 | 1 | 2 | 3 | - | - | - | - | - | - | - | - | ||||||
| Other Notes Payable Current | - | - | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 3 | 3 | 4 | 9 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | ||||||
| Liabilities | 3 | 3 | 4 | 9 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 35 | 35 | 34 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -38 | -37 | -38 | -10 | -6 | -6 | -6 | -6 | -6 | -5 | -5 | -5 | ||||||
| Stockholders Equity | -3 | -3 | -3 | -9 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -4 | ||||||
| Debt Instrument Unamortized Discount | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Debt Instrument Unamortized Discount Current | - | - | - | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Debt Instrument Unamortized Discount Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 47 | 47 | 47 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | ||||||
| Shares Outstanding | 47 | 47 | 47 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBalance Labs, Inc. (BLNC) — SEC Financial Statements & Analysis
Balance Labs, Inc. (BLNC) is a services-management consulting services company, incorporated in DE. Balance Labs, Inc. trades on OTC as: BLNC. Balance Labs, Inc. (BLNC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Balance Labs, Inc. carries a market cap of $72.62M, a P/E ratio of -2.29x, a P/B ratio of -26.18x, a P/S ratio of 1815.53x, an enterprise value of $72.53M, and an EV/EBITDA multiple of -5.20x. On profitability, it posts an operating margin of -34840.38%, a net margin of -79187.04%, a Return on Equity (ROE) of 792.16%, and a Return on Assets (ROA) of -31053.28%. Per share, it reports EPS of $-0.68, diluted EPS of $-0.68, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 6739.32% year-over-year, and EPS growth of 3063.89% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.04x, working capital of $-2.77M, a debt-to-equity ratio of -1.05x, a debt ratio of 22.88, an interest coverage ratio of -119.81x, free cash flow of $-440.96K (TTM), and net debt of $-92.47K. Figures sourced from SEC EDGAR.
- Market Cap
- $72.62M
- P/E TTM
- -2.29x
- EPS TTM
- $-0.68
- P/B TTM
- -26.18x
- ROE TTM
- 792.16%
- ROA TTM
- -31053.28%
- Debt To Equity
- -1.05x
- Free Cash Flow TTM
- $-440.96K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Balance Labs, Inc. in?
Balance Labs, Inc. (BLNC) operates in the Services-Management Consulting Services industry.
What exchange does BLNC trade on?
Balance Labs, Inc. (BLNC) trades on the OTC.
Where is Balance Labs, Inc. incorporated?
Balance Labs, Inc. is incorporated in DE.
When was Balance Labs, Inc. (BLNC)'s most recent SEC filing?
Balance Labs, Inc. (BLNC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is BLNC's market cap?
Balance Labs, Inc. (BLNC) has a market capitalization of $72.62M as of 2026-06-30.
What is BLNC's EPS (earnings per share)?
Balance Labs, Inc. (BLNC)'s trailing twelve month EPS is $-0.68 as of 2026-06-30.
What is BLNC's ROE (return on equity)?
Balance Labs, Inc. (BLNC)'s trailing twelve month Return on Equity (ROE) is 792.16% as of 2026-06-30.
What is BLNC's ROA (return on assets)?
Balance Labs, Inc. (BLNC)'s trailing twelve month Return on Assets (ROA) is -31053.28% as of 2026-06-30.
What is BLNC's EV/EBITDA?
Balance Labs, Inc. (BLNC)'s trailing twelve month EV/EBITDA is -5.20x as of 2026-06-30.